FluGen
Blood & Organ Banks · Wisconsin, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
597 Science Dr Ste 10, Madison, Wisconsi...Phone Number
(608) 441-2729Website
www.flugen.comRevenue
$8 MillionIndustry
About FluGen
FluGen Inc. is dedicated to developing a more effective influenza vaccine, specifically the M2SR Vaccine Platform, which aims to address significant unmet needs in flu prevention. Their flagship candidate, M2SR, is an intranasal, supra-seasonal flu vaccine that enhances immune response and shows promise against influenza and respiratory diseases. The company targets the elderly and young populations who are most at risk from influenza, with long-term plans to expand its vaccine technology to combat COVID-19 and other respiratory illnesses. FluGen's innovative approach seeks to revolutionize the influenza market by providing consistent efficacy and protection against virus drift.Explore more
SIC Code 28,283NAICS Code 32,325Show moreFluGen Org Chart
Compare Similar Companies to FluGen
Compare insights from companies similar to FluGen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
FluGen Tech Stack
A closer look at the technologies used by FluGen
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding FluGen
Sign Up For FreeTo access detailed company insights
FluGen Inc. is dedicated to developing a more effective influenza vaccine, specifically the M2SR Vaccine Platform, which aims to address significant unmet needs in flu prevention. Their flagship candidate, M2SR, is an intranasal, supra-seasonal flu vaccine that enhances immune response and shows promise against influenza and respiratory diseases. T... Read More